Episode 46: Dr. Carsten Rudolph, CEO and Managing Director at Ethris

from Few & Far Between: How Biotech Gets Built · host Chris O'Brien

"It's really a very important challenge we had from the very beginning, to see how to stabilize nanoparticles with the messenger RNA so they are not destroyed during nebulization." - Dr. Carsten Rudolph, CEO and Managing Director at Ethris Welcome to the latest episode of Biorasi's Few & Far Between podcast. Join host Chris O'Brien and guest, Dr. Carsten Rudolph, as they discuss the current state and bright future of nasal vaccine technology. Tune in today!

Episode metadata supplied by the publisher feed · Published Dec 12, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

Episode 46: Dr. Carsten Rudolph, CEO and Managing Director at Ethris

0:00 37:26

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Few & Far Between: How Biotech Gets Built?

This episode is 37 minutes long.

When was this Few & Far Between: How Biotech Gets Built episode published?

This episode was published on December 12, 2024.

Can I download this Few & Far Between: How Biotech Gets Built episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!